ArticleAmerican journal of human genetics1993
Insurance and genetic testing: where are we now?
Article in American journal of human genetics, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Insurance underwriting in the genetic era.American journal of human genetics · 1997Review
- Questioning the need for anonymous genetic counseling and testing.American journal of human genetics · 1996Article
- Individual, family, and societal dimensions of genetic discrimination: a case study analysis.Science and engineering ethics · 1996Article
- Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors.American journal of human genetics · 1995Article
- Attitudes toward genetic testing for colon cancer risk.American journal of public health · 1995Article
- Genetic testing and insurance. The Ad Hoc Committee on Genetic Testing/Insurance Issues.American journal of human genetics · 1995Article
- Human genome research and the public interest: progress notes from an American science policy experiment.American journal of human genetics · 1994Review
- Genetic conditions and the scope of the Americans with Disabilities Act.American journal of human genetics · 1993Article
- Anticipating unfair uses of genetic information.American journal of human genetics · 1993Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
Basic research will spur development of genetic tests that are capable of presymptomatic prediction of disease, disability, and premature death in presently asymptomatic individuals. Concerns have been expressed about potential harms related to the use of genetic test results, especially loss of confidentiality, eugenics, and discrimination. Existing laws and administrative policies may not be sufficient to assure that genetic information is used fairly. To provide factual information and conceptual principles upon which sound social policy can be based, the Human Genome Initiative established an Ethical, Legal, and Social Issues Program. Among the first areas to be identified as a priority for study was insurance. This paper provides a review of life, health, and disability insurance systems, including basic principles, risk classification, and market and regulatory issues, and examines the potential impact of genetic information on the insurance industry.
Indexed as
Identifiers
8447322PMC1682164What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.